Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP391538.RAIoQIvNUmA1ggJWi5rYWlFlxV1ck3Qtmhc_WecFXf_kU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP391538.RAIoQIvNUmA1ggJWi5rYWlFlxV1ck3Qtmhc_WecFXf_kU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP391538.RAIoQIvNUmA1ggJWi5rYWlFlxV1ck3Qtmhc_WecFXf_kU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP391538.RAIoQIvNUmA1ggJWi5rYWlFlxV1ck3Qtmhc_WecFXf_kU130_provenance.
- NP391538.RAIoQIvNUmA1ggJWi5rYWlFlxV1ck3Qtmhc_WecFXf_kU130_assertion description "[PTPN12 interacts with the same T cell activation accessory molecules, Grb2 and Csk kinase, as the Graves' disease (GD) associated PTPN22 encoded lymphoid tyrosine phosphatase (LYP) molecule and also plays a key role in T cell receptor signalling, leading to the hypothesis that it too may be involved in GD susceptibility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP391538.RAIoQIvNUmA1ggJWi5rYWlFlxV1ck3Qtmhc_WecFXf_kU130_provenance.
- NP391538.RAIoQIvNUmA1ggJWi5rYWlFlxV1ck3Qtmhc_WecFXf_kU130_assertion evidence source_evidence_literature NP391538.RAIoQIvNUmA1ggJWi5rYWlFlxV1ck3Qtmhc_WecFXf_kU130_provenance.
- NP391538.RAIoQIvNUmA1ggJWi5rYWlFlxV1ck3Qtmhc_WecFXf_kU130_assertion SIO_000772 17608818 NP391538.RAIoQIvNUmA1ggJWi5rYWlFlxV1ck3Qtmhc_WecFXf_kU130_provenance.
- NP391538.RAIoQIvNUmA1ggJWi5rYWlFlxV1ck3Qtmhc_WecFXf_kU130_assertion wasDerivedFrom befree-20140225 NP391538.RAIoQIvNUmA1ggJWi5rYWlFlxV1ck3Qtmhc_WecFXf_kU130_provenance.
- NP391538.RAIoQIvNUmA1ggJWi5rYWlFlxV1ck3Qtmhc_WecFXf_kU130_assertion wasGeneratedBy ECO_0000203 NP391538.RAIoQIvNUmA1ggJWi5rYWlFlxV1ck3Qtmhc_WecFXf_kU130_provenance.
- befree-20140225 importedOn "2014-02-25" NP391538.RAIoQIvNUmA1ggJWi5rYWlFlxV1ck3Qtmhc_WecFXf_kU130_provenance.